<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000508532">
  <TermName>Xeloda</TermName>
  <TermPronunciation>(zeh-LOH-duh)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used alone or with other drugs to treat  certain types of colorectal cancer, breast cancer, esophageal cancer, gastroesophageal junction cancer, stomach cancer, and pancreatic cancer.  It is also being studied in the treatment of other types of cancer. Xeloda is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Xeloda is a type of antimetabolite. Also called capecitabine.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718224" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Xeloda&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718223" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Xeloda&quot;" language="es" id="_4"/>
  <SpanishTermName>Xeloda</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa solo o con otros medicamentos para el tratamiento de ciertos tipos de cáncer colorrectal,  cáncer de mama, cáncer de esófago, cáncer de unión gastroesofágica, cáncer de estómago y cáncer de páncreas. También está en estudio para el tratamiento de otros tipos de cáncer. Las células cancerosas absorben Xeloda que se descompone en fluorouracilo, una sustancia que destruye  células cancerosas. Xeloda es un tipo de antimetabolito. También se llama capecitabina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2006-09-15</DateFirstPublished>
  <DateLastModified>2023-01-05</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000496354" url="/about-cancer/treatment/drugs/capecitabine">Capecitabine</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
